Ekso Bionics Holdings designs, develops, and sells exoskeleton technology. Co.'s exoskeleton technology serves several markets and can be used both by able-bodied persons as well as by persons with physical disabilities. Co. has sold or leased devices that enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again; assist individuals with a range of impairments, and allow industrial workers to perform repetitive work for extended periods. Co.'s product, the Ekso GT, is a wearable bionic suit that is used by its customers in both in-patient and out-patient settings. EksoUE is a wearable assistive device. The EKSO stock yearly return is shown above.
The yearly return on the EKSO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2015 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the EKSO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|